Innoviva Stock Forecast for 2023 - 2025 - 2030
Updated on 12/07/2023
Innoviva Stock Forecast and Price Target
The average target price for Innoviva's stock set by renowned analysts in recent months is $15.00, representing a potential upside of approximately 3.88% from its last closing price if met by 2024. This estimation is based on a high estimate of $15.00 and a low estimate of $15.00. If you are interested in INVA stock, it is important to also consider its competitors.
3.88% Upside
Innoviva Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Innoviva's Price has decreased by 81.82%, going from $11.00 to $2.00. In the next year, analysts believe that Fair Value will reach $12.84 – an increase of 542.31%. For the next nine years, the forecast is for Fair Value to grow by 332.86%.
Innoviva Revenue Forecast for 2023 - 2025 - 2030
Innoviva's Revenue has seen impressive growth In the last three years, rising from $261.02M to $331.34M – a growth of 26.94%. 1 analysts predict Innoviva's Revenue will decrease by 9.42% in the next year, reaching $300.14M. For the next ten years, the forecast is for Revenue to grow by 6.98%.
.jpg)
Innoviva Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last three years, Innoviva's Free Cash Flow has decreased from $257.45M to $201.66M – a 21.67% drop! Analysts predict that Innoviva's Free Cash Flow will increase in the upcoming year, reaching $234.39M. This would represent an increase of 16.23%. Over the next eight years, experts predict that Innoviva's Free Cash Flow will grow at a rate of 40.76%.
Innoviva Net Income Forecast for 2023 - 2025 - 2030
In the last three years, Innoviva's Net Income has grown, moving from $157.29M to $213.92M – an increase of 36.00%. In the following year, the 1 analysts surveyed believe that Innoviva's Net Income will decrease by 32.76%, reaching $143.85M. According to professionals, by 2030, Innoviva's Net Income will have decreased by 54.80%, falling down to $96.70M.
Innoviva EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Innoviva has seen a decline in its EBITDA, from $249.51M to $217.98M – a 12.64% decrease. According to the 1 analysts polled, in the next year, Innoviva's EBITDA will fall by 33.75%, reaching $144.42M. By 2030, professionals believe that Innoviva's EBITDA will have decreased by 36.80%, falling to $137.76M.
Innoviva EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Innoviva's EBIT has decreased by 14.90%, from $249.46M to $212.30M. For the next year, 1 analysts project Innoviva's EBIT to drop by 45.50%, reaching $115.71M. By 2030, professionals believe that Innoviva's EBIT will decrease by 45.08%, reaching $116.59M – a concerning trend for the company.
Innoviva EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Innoviva's EPS has decreased by 81.82%, going from $1.43 to $0.26. In the next year, analysts believe that EPS will reach $1.67 – an increase of 542.31%. For the next nine years, the forecast is for EPS to grow by 332.86%.
.jpg)